Transplant Dysfunction
9
2
2
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (9)
Expanding the Scope of Post-transplant HLA-specific Antibody Detection and Monitoring in Renal Transplant Recipients
Prehabilitation in Patients on a Waiting List for a Transplant
Cf-DNA Assay During Treatment of Acute Rejection
Liver Transplantation After ex Vivo Liver Perfusion
Prediction of Pulmonary Graft Dysfunction After Double-lung Transplantation (PGD3-AI Study)
Remote Ischaemic Preconditioning in Transplantation (RIPTRANS)
Hemodynamic Optimization During Single Kidney Transplantation With MostcareUP
Safety and Effect of Low-Energy Extracorporeal Shockwave Therapy (ESWT) on the Renal Allograft in Transplant Recipients.
Effects of Proton Pump Inhibitors on Kidney Transplant Recipients